A heparan sulfate-targeted conditionally replicative adenovirus, Ad5.pk7-Delta24, for the treatment of advanced breast cancer.
about
shRNA-armed conditionally replicative adenoviruses: a promising approach for cancer therapyPromising oncolytic agents for metastatic breast cancer treatmentOncolytic virus therapy for pancreatic cancer using the adenovirus library displaying random peptides on the fiber knob.Evaluation of adenovirus capsid labeling versus transgene expressionNoninvasive monitoring of mRFP1- and mCherry-labeled oncolytic adenoviruses in an orthotopic breast cancer model by spectral imaging.Targeting cancer-initiating cells with oncolytic viruses.Effect of adenoviral delivery of prodynorphin gene on experimental inflammatory pain induced by formalin in ratsDirecting systemic oncolytic viral delivery to tumors via carrier cellsGene therapy of gynaecological diseases.Cancer, stem cells, and oncolytic viruses.Adenoviral vector-based strategies for cancer therapy.New insights on adenovirus as vaccine vectors.Tropism-modification strategies for targeted gene delivery using adenoviral vectors.Killing effect of TNF-mediated by conditionally replicating adenovirus on esophageal cancer and lung cancer cell lines.Ad5/3-9HIF-Delta24-VEGFR-1-Ig, an infectivity enhanced, dual-targeted and antiangiogenic oncolytic adenovirus for kidney cancer treatment.Hitting the nail on the head: combining oncolytic adenovirus-mediated virotherapy and immunomodulation for the treatment of glioma.Designer Oncolytic Adenovirus: Coming of Age.
P2860
Q26765364-58843E51-DD90-4407-B62E-3165ADBA31CEQ26830620-2D312D69-6196-47CD-8FE0-5A1C927071DCQ33410245-61FC16D7-5857-4CF8-B76E-E2E7A72C712CQ33669272-9017D529-25B0-41E5-9EBC-5EE45DD085A4Q34187531-F1E00A3B-B1E8-45A2-96EA-64F3F4DED6EDQ34659011-ADD31215-4B5C-4EBC-A44D-0A442D361220Q35016982-5974ABE3-3018-4D1E-936B-3A4AE4E3351CQ35029126-FA561A0C-8FA3-483D-98FB-D5514CF8EAF7Q36922247-7A9EFEE5-59AA-4736-9963-4E0A9790F8F6Q37209758-15039EDE-D3E8-4ACD-9EB4-6083FD72E1F6Q37409025-37EC6548-9A75-4636-859D-041070224B7AQ37513550-5D310CB8-52ED-4020-A64E-31103D4FB8C9Q38614156-D8E907C0-E803-4F33-8D06-D69F5380A095Q38798490-BCD1DF97-D198-4357-975B-70C23B15E72CQ39851910-63F7D35F-4594-41F1-B4F8-828DE4520706Q47141309-DFB593E6-AEF9-48E4-9ADA-791B45CB18A8Q55467684-BABFF460-0CFD-4887-B993-92112731D9D4
P2860
A heparan sulfate-targeted conditionally replicative adenovirus, Ad5.pk7-Delta24, for the treatment of advanced breast cancer.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
2006年论文
@zh
2006年论文
@zh-cn
name
A heparan sulfate-targeted con ...... ent of advanced breast cancer.
@ast
A heparan sulfate-targeted con ...... ent of advanced breast cancer.
@en
type
label
A heparan sulfate-targeted con ...... ent of advanced breast cancer.
@ast
A heparan sulfate-targeted con ...... ent of advanced breast cancer.
@en
prefLabel
A heparan sulfate-targeted con ...... ent of advanced breast cancer.
@ast
A heparan sulfate-targeted con ...... ent of advanced breast cancer.
@en
P2093
P2860
P356
P1433
P1476
A heparan sulfate-targeted con ...... ment of advanced breast cancer
@en
P2093
A Hemminki
A Ristimäki
L Kangasniemi
M Särkioja
S Goodison
T Hakkarainen
P2860
P2888
P356
10.1038/SJ.GT.3302830
P577
2006-08-10T00:00:00Z